Ventas Past Earnings Performance
Past criteria checks 0/6
Ventas's earnings have been declining at an average annual rate of -59.1%, while the Health Care REITs industry saw earnings declining at 7.1% annually. Revenues have been growing at an average rate of 3.7% per year.
Key information
-59.1%
Earnings growth rate
-59.9%
EPS growth rate
| Health Care REITs Industry Growth | -12.2% |
| Revenue growth rate | 3.7% |
| Return on equity | -0.6% |
| Net Margin | -1.6% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Ventas: The Silver Tsunami Vs. A Decade Of Underperformance
Mar 27Ventas: Careful After The Outperformance (Rating Downgrade)
Dec 25Ventas Looks Ready To Return To Pre-COVID Highs
Nov 21Ventas: Offering Passive Income Investors A Solid 4.3% Yield
Sep 12Ventas: A High-Quality Entry Point For Quality Healthcare
Aug 18Ventas: Time For This REIT To Capitalize On The Silver Tsunami
Aug 09Ventas: Blowout Performance From SHOP
Jun 23Ventas: High Quality At An Attractive Price
Feb 16Ventas FFO of $0.73 in-line, revenue of $1.05B beats by $10M
Feb 09Ventas declares $0.45 dividend
Dec 08Ventas: 4.1% Yield, Low Valuation, Dip-Buying Opportunity
Sep 25Ventas declares $0.45 dividend
Sep 16Ventas FFO of $0.72 in-line, revenue of $1.02B misses by $20M
Aug 04Ventas: Tough Road Ahead To A Growth Trajectory
Jun 01Ventas: A REIT Recovery Play With A Rock-Solid 3% Yield
Mar 23Revenue & Expenses BreakdownBeta
How Ventas makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 4,615 | -73 | 153 | 0 |
| 31 Dec 23 | 4,500 | -41 | 149 | 0 |
| 30 Sep 23 | 4,359 | 5 | 146 | 0 |
| 30 Jun 23 | 4,256 | 77 | 148 | 0 |
| 31 Mar 23 | 4,173 | -69 | 147 | 0 |
| 31 Dec 22 | 4,116 | -47 | 145 | 0 |
| 30 Sep 22 | 4,079 | -43 | 140 | 0 |
| 30 Jun 22 | 4,019 | 16 | 135 | 0 |
| 31 Mar 22 | 3,921 | 145 | 132 | 0 |
| 31 Dec 21 | 3,818 | 49 | 130 | 0 |
| 30 Sep 21 | 3,760 | 200 | 131 | 0 |
| 30 Jun 21 | 3,701 | 152 | 133 | 0 |
| 31 Mar 21 | 3,703 | -91 | 130 | 0 |
| 31 Dec 20 | 3,790 | 439 | 130 | 0 |
| 30 Sep 20 | 3,847 | 340 | 135 | 0 |
| 30 Jun 20 | 3,911 | 413 | 143 | 0 |
| 31 Mar 20 | 3,925 | 780 | 158 | 0 |
| 31 Dec 19 | 3,859 | 433 | 159 | 0 |
| 30 Sep 19 | 3,781 | 484 | 163 | 0 |
| 30 Jun 19 | 3,720 | 501 | 162 | 0 |
| 31 Mar 19 | 3,714 | 457 | 156 | 0 |
| 31 Dec 18 | 3,702 | 409 | 146 | 0 |
| 30 Sep 18 | 3,668 | 740 | 148 | 0 |
| 30 Jun 18 | 3,646 | 1,252 | 142 | 0 |
| 31 Mar 18 | 3,607 | 1,237 | 139 | 0 |
| 31 Dec 17 | 3,568 | 1,357 | 135 | 0 |
| 30 Sep 17 | 3,560 | 1,172 | 132 | 0 |
| 30 Jun 17 | 3,527 | 707 | 130 | 0 |
| 31 Mar 17 | 3,481 | 699 | 129 | 0 |
| 31 Dec 16 | 3,447 | 650 | 127 | 0 |
| 30 Sep 16 | 3,410 | 569 | 123 | 0 |
| 30 Jun 16 | 3,369 | 465 | 124 | 0 |
| 31 Mar 16 | 3,331 | 453 | 125 | 0 |
| 31 Dec 15 | 3,284 | 407 | 128 | 0 |
| 30 Sep 15 | 3,171 | 366 | 129 | 0 |
| 30 Jun 15 | 3,049 | 412 | 126 | 0 |
| 31 Mar 15 | 2,836 | 361 | 123 | 0 |
| 31 Dec 14 | 2,772 | 376 | 122 | 0 |
| 30 Sep 14 | 2,776 | 398 | 124 | 0 |
| 30 Jun 14 | 2,783 | 435 | 123 | 0 |
| 31 Mar 14 | 2,868 | 487 | 119 | 0 |
| 31 Dec 13 | 2,514 | 374 | 115 | 0 |
| 30 Sep 13 | 2,729 | 483 | 108 | 0 |
| 30 Jun 13 | 2,673 | 471 | 106 | 0 |
Quality Earnings: VTR is currently unprofitable.
Growing Profit Margin: VTR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VTR is unprofitable, and losses have increased over the past 5 years at a rate of 59.1% per year.
Accelerating Growth: Unable to compare VTR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VTR is unprofitable, making it difficult to compare its past year earnings growth to the Health Care REITs industry (15.2%).
Return on Equity
High ROE: VTR has a negative Return on Equity (-0.63%), as it is currently unprofitable.